tiprankstipranks
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market
ACTU
Actuate Therapeutics, Inc.
RESEARCH TOOLSreports

Actuate Therapeutics, Inc. (ACTU) Income Statement

34 Followers

Actuate Therapeutics, Inc. Income Statement

Last quarter (Q4 2025), Actuate Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Actuate Therapeutics, Inc.'s net income was $-4.55M. See Actuate Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 22.50M$ 25.16M$ 24.97M$ 20.21M
Depreciation and Amortization
$ 0.00$ 2.14M$ 272.85K$ 63.61K
EBITDA
$ -22.50M$ -25.16M$ -24.43M$ -20.08M
Operating Income
$ -22.50M$ -25.16M$ -24.97M$ -20.21M
Other Income/Expenses
$ 267.46K$ -2.12M$ 229.21K$ 47.41K
Pretax Income
$ -22.23M$ -27.28M$ -24.74M$ -20.16M
Net Income
$ -22.23M$ -27.29M$ -24.74M$ -20.16M
Per Share Metrics
Basic EPS
$ -1.06$ -3.26$ -1.65$ -1.34
Diluted EPS
$ -1.06$ -3.26$ -1.65$ -1.34
Weighted Average Shares Outstanding
 21.02M 19.51M 15.03M 15.03M
Weighted Average Shares Outstanding (Diluted)
 21.02M 19.51M 15.03M 15.03M
Currency in USD

Actuate Therapeutics, Inc. Earnings and Revenue History